03 jun: Nedturen har skabt spændende købsmuligheder
07 jun: NETWORKING – SPILD AF TID ELLER GENVEJEN TIL SUCCES?
06-06-2012 11:13:00

UPDATE: Retailer Ahold Profits Down as Price Competition Weighs

-- Profits fall due to margin pressure

-- Intense price competition will remain throughout 2012

-- Current margin levels will continue in 2012

-- Sales trend is improving during 1Q and into 2Q

(Adds detail throughout and CEO, analyst comments, share price.)

By Robert van den Oever

Of DOW JONES NEWSWIRES

AMSTERDAM--Retailer Royal Ahold NV (AH.AE), which runs the Stop & Shop and Giant supermarket chains in the U.S., Wednesday posted a slight fall in first-quarter net profit as intense price competition weighed on margins.

Ahold expects 2012 to be challenging, with price competition continuing and consumer spending under pressure, said Chief Executive Mr Dick Boer, although he added that he's encouraged by the improving sales trend in the second quarter. He expects the current low margin levels to continue as Ahold keeps investing to maintain low prices.

The company is outperforming Belgian rival Delhaize Group (DELB.BT) in the U.S., even though its flagship chains have faced fierce competition as retailers battled to lure increasingly price-sensitive customers. Delhaize, like Ahold, makes more than half of its sales in the U.S., but Ahold gained market share there during the first quarter with increased promotional activity. The company doesn't give a figure for its U.S. market share.

In the Netherlands, which accounts for a third of Ahold's sales, the retailer is suffering from low consumer confidence as shoppers grapple with the government's austerity measures, although it managed to maintain its market share. Its core chain, Albert Heijn, has around 33% market share, which is expected to grow due to the recent acquisition of 82 stores from competitor Jumbo.

Ahold said it is on target to deliver EUR350 million in cost savings for the next three years.

In the three months to March 31, the retailer's net profit fell 3.1% to EUR282 million from EUR291 million a year earlier. Analysts had forecast a rise to EUR305 million, according to FactSet.

Net sales totaled EUR9.71 billion, up 5% from a year earlier, short of analysts' expectations for EUR9.81 billion. Sales growth was a healthy 2.8% in the U.S. and a modest 1.2% in the Netherlands. Underlying margin dropped to 4.3% from 4.6% and operating result was down 6.3% to EUR416 million.

Analysts were disappointed with the numbers.

"The results are meager, but not dramatic given the intense price competitive market environment", said ABN Amro analyst Robert Jan Vos, who rates Ahold stock at hold with a EUR12 price target.

Richard Withagen from SNS Securities said the U.S. sales growth is disappointing and Netherlands growth weak. He rates the stock at buy, with a EUR11.50 price target.

However, analysts at Rabobank said they see room for the first signs of accelerating sales growth and stable margins in the second half. Rabo, which rates the stock at buy with a EUR12 target, said the shares are not overly expensive and offer a good buy in a troubled sector.

Ahold's sales and profits are expected to benefit from the consolidation of its recent acquisitions, online retailer Bol.com and 82 stores in the Netherlands from Jumbo.

Delhaize last month swung to a first-quarter net loss, which it attributed to charges related to store closures in the U.S. under its unprofitable Food Lion brand, as well as openings under its discount Bottom Dollar chain. Its volumes have taken a tumble after it raised prices at Food Lion in an effort to pass on cost inflation to customers, but improved in the first quarter from the fourth quarter of 2011. The Belgian company said underlying operating profit is this year expected to decrease by 15% to 20% at identical exchange rates compared with 2011--far below market expectations.

Ahold is in the process of putting its EUR2.6-billion cash pile to better use, with a focus on organic growth and acquisitions. It opens a fifth store Wednesday in Belgium, aiming for 10 by the end of 2012 and 50 in the next five years. It will open its first German store in the third quarter.

At 0800 GMT, Ahold shares were down 2.6% at EUR9.34, against the benchmark AEX index which was up 1.5%.

Write to Robert van den Oever at robert.vandenoever@dowjones.com

(END) Dow Jones Newswires

June 06, 2012 05:13 ET (09:13 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
19 feb
 
Jeg tager hatten for dit velbegrunede og fyldestgørende indlæg til debatten. Det kunne mange lære af..
32
21 feb
GEN
Det er altid rart at møde et ungt menneske, der har potentiale til at blive klogere.
26
23 feb
ZEAL
Jeg har tildigere her på EI rapporteret at Soliqua ville blive lanceret i Sydkorea. Nu har Sanofi af..
25
21 feb
GEN
Du bliver da dummere og dummere at høre på 
21
24 feb
NRDF
  Aktieugen er overstået og desværre, men ikke særligt overraskende, viste det sig igen, at det dans..
15
23 feb
ZEAL
Sanofi og  har for et par dage siden oplyst på clinicaltrial.gov at de starter studiet «LixiPark» me..
14
23 feb
GEN
H2 2018 er pakket med nyheder og kliniske data fra daratumumab i solide tumorer er en af de største ..
13
21 feb
TRMD-A
Mange års erfaring i teknisk analyse berettiger mig til at give dig følgende svar:    Torm viser akt..
12
20 feb
 
Helt korrekt. Jeg skiftede job i 2007 og har på denne ene pension fra dette tidspunkt indbetalt 648...
12
19 feb
 
Min egen opfattelse er at det er et sted, hvor nye investor kan stille spørgsmål, og få en brugbart ..
12

Aktier/tendens: William Demant kan tage fokus i grøn åbning

23-02-2018 08:27:52
Der er udsigt til stigninger fredag morgen, når aktiemarkedet herhjemme åbner. Fra åbningen kan William Demant igen tage fokus, efter at selskabet har fået hævet kursmålet af en stribe finanshuse ovenpå torsdagens positive regnskab. I USA lukkede S&P 500 torsdagens handel med et plus på 0,2 pct., mens også Dow Jones lukkede med en gevinst på 0,7 pct. Til gengæld faldt Nasdaq med 0,1 pct. Futures f..

Aktier/middag: Genmab buldrer frem med WDH og ISS som følgesvende

22-02-2018 11:40:57
Biotekselskabet Genmab ligger helt i top i det danske eliteindeks torsdag middag efter at have præsenteret regnskab onsdag aften. Også ISS og William Demant, der begge kom med regnskab for fjerde kvartal torsdag morgen, er med i toppen.Men det er onsdagens regnskab fra Genmab, der trækker den helt store opmærksomhed, efter at biotekselskabet gjorde markedets bekymringer over en mulig skuffende pro..

ISS: Salget vokser mens bundlinjen skrumper

22-02-2018 08:39:00
ISS kan se bundlinjen falde tilbage i 2017 sammenlignet med i 2016, selvom selskabet er vokset på salget.Omsætningen i selskabet voksede til 79.912 mio. kr. i 2017, mens omsætningen udgjorde 78.658 mio. kr. i 2016.Omvendt steg nettoresultatet i 2017 til 2007 mio. kr. mod 2220 mio. kr. året før.Af regnskabet fremgår det, at årsagen til at bundlinjen ikke vokser med toplinjen, blandt andet er ekster..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. februar 2018 19:01:03
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20180222.1 - EUROWEB3 - 2018-02-25 19:01:03 - 2018-02-25 19:01:03 - 1 - Website: OKAY